Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, May 22, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Yi Chen Reiterated (ANGO) at Strong Buy and Held Target at $14 on, May 22nd, 2024
Yi Chen of HC Wainwright & Co., Reiterated "AngioDynamics, Inc." (ANGO) at Strong Buy and Held Target at $14 on, May 22nd, 2024.
Yi has made no other calls on ANGO in the last 4 months.
There is 1 other peer that has a rating on ANGO. Out of the 1 peers that are also analyzing ANGO, 0 agree with Yi's Rating of Hold.
This is the rating of the analyst that currently disagrees with Yi
- Steven Lichtman of "Oppenheimer" Upgraded from Hold to Buy and Held Target at $12 on, Friday, April 5th, 2024
